Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    1.50 (1.35%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £67.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

7 Oct 2014 07:00

RNS Number : 5791T
Intercede Group PLC
07 October 2014
 



7 October 2014

Intercede Group plc

("Intercede" or the "Group")

 

Trading Update

 

We are pleased to report high levels of interest in the Group's new and exciting mobile digital identity technology. This further validates the size of the opportunity for Intercede's technology as people better understand the security implications of areas such as the Internet of Things, the Cloud, and the inherent limitations of usernames and passwords.

As previously reported, Intercede continues to invest heavily in research and development resulting in the recent launch of MyID v9 Service Pack 2 and MyID v10.1 to meet the US government's new FIPS 201-2 standard. On 29 September 2014, Intercede announced the first customer for the deployment of a derived credentials based identity solution for mobile devices.

In the meantime, Intercede's smart card related identity business remains strong. However, the order book and associated revenues are subject to the timing of receipt of a relatively small number of large orders and seasonal variations mainly due to the US government fiscal year.

Against this backdrop, revenues in the first half of the current financial year will be in the region of £4.0 million (2013: £4.6 million) and cash balances at the end of September totalled £6.3 million (30 September 2013: £7.4 million) reflecting the investment outlined above.

Management remain optimistic that full year growth expectations will be achieved subject to the timing of receipt of orders, both from smart card related projects and from a number of mobile related opportunities.

A further update will be provided when the Group's Interim Results are released towards the end of November 2014.

 

Enquiries

 

Intercede Group plcTel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director

 

finnCap LtdTel. +44 (0)207 220 0500Stuart Andrews, Corporate FinanceJoanna Weaving, Corporate Broking

 

Bell PottingerTel. +44 (0)7802 442486Archie Berens

 

 

 

About Intercede

Intercede is a software company specialising in identity and credential management with a global team of experts located in the US and UK.

Intercede's MyID software enables organisations to create and use trusted digital identities for employees, citizens and machines. This allows secure access to services, facilities, information and networks.

MyID meets the highest government standards yet is simple enough to be deployed onto consumer devices such as smartphones and tablets. Critically, MyID provides an easy, convenient and secure alternative to passwords.

Millions of identities are managed using MyID and Intercede has provided identity verification and management services to global customers for more than twenty years. MyID is a commercial-off-the-shelf software product, designed and developed to be configurable so it can be embedded as the cornerstone of cybersecurity infrastructure for governments and corporations.

Customers trusting Intercede for secure digital identity include the US and UK governments and some of the world's largest corporations, telecommunications providers and information technology partners.

For more information visit: www.intercede.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSMFIMFLSELS
Date   Source Headline
6th Nov 20147:00 amRNSShare Buyback Programme
6th Nov 20147:00 amRNSHalf Yearly Report
7th Oct 20147:00 amRNSTrading Update
29th Sep 20147:00 amRNSFirst Customer: Derived Credentials for Mobile
17th Sep 20144:25 pmRNSResult of AGM
1st Aug 20147:00 amRNSShare Incentive Plan
26th Jun 20149:37 amRNSDirector/PDMR Shareholding
25th Jun 20141:20 pmRNSDirector Share Dealings
10th Jun 20147:00 amRNSDirector Share Dealings
5th Jun 20147:00 amRNSFinal Results
6th May 201410:32 amRNSShare Incentive Plan
1st Apr 20147:00 amRNSDirectorate Change
27th Mar 20147:00 amRNSTransaction in Own Shares
25th Mar 201410:35 amRNSTransfer of Treasury Shares
20th Mar 20147:00 amRNSTransaction in Own Shares
13th Mar 20147:00 amRNSTransfer of Treasury Shares
13th Mar 20147:00 amRNSShare Incentive Plan
4th Mar 20149:09 amRNSTransaction in Own Shares
27th Feb 20147:00 amRNSTransaction in Own Shares
13th Feb 20147:00 amRNSTransaction in Own Shares
7th Feb 20147:00 amRNSPartnership with TELUS and Gemalto
5th Feb 20147:00 amRNSTransaction in Own Shares
28th Jan 201411:30 amRNSTransaction in Own Shares
13th Jan 20147:00 amRNSShare Buyback Programme
8th Jan 20147:00 amRNSTrading Update
10th Dec 20136:00 pmRNSDirector Share Dealings
10th Dec 20134:49 pmRNSDirector Share Dealings
21st Nov 20137:00 amRNSHalf Yearly Report
5th Nov 20137:00 amRNSNew Contract Win
1st Oct 20137:00 amRNSDirector Share Dealings
26th Sep 20137:00 amRNSDirector/PDMR Shareholding
25th Sep 20131:00 pmRNSResult of AGM
25th Sep 20137:00 amRNSContract Wins and AGM Statement
9th Sep 20137:00 amRNSDirectors' Holding
29th Jul 20137:00 amRNSContract awards and Trading update
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
4th Jun 20137:00 amRNSFinal Results
25th Apr 20137:00 amRNSContract Win
16th Apr 20137:00 amRNSAppointment of Non-Executive Director
5th Apr 20137:00 amRNSYear end trading update
1st Feb 20137:00 amRNSTrading Update
3rd Dec 20127:00 amRNSHolding(s) in Company
22nd Nov 20127:00 amRNSInterim Results
4th Oct 20127:00 amRNSTrading Update
26th Sep 20124:39 pmRNSResult of AGM
21st Aug 20127:00 amRNSAmendments to LTIP
4th Jul 20123:35 pmRNSDirector/PDMR Shareholding
14th Jun 20122:37 pmRNSIssue of Equity
12th Jun 201210:13 amRNSDirector/PDMR Shareholding and Issue of equity
5th Apr 20127:00 amRNSYear End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.